Clarithromycin is an antibiotic of the macrolide class used to treat infections caused by various bacteria including Streptococcus pneumoniae, Haemophilus influenzae, Mycobacterium avium, and Helicobacter pylori. It works by inhibiting bacterial protein synthesis. Common adverse effects include nausea, diarrhea and abdominal pain. It should not be used in those with hypersensitivity to macrolides or a history of QT prolongation. Nurses monitor for therapeutic effects and superinfections, and ensure proper administration.
Clarithromycin is an antibiotic of the macrolide class used to treat infections caused by various bacteria including Streptococcus pneumoniae, Haemophilus influenzae, Mycobacterium avium, and Helicobacter pylori. It works by inhibiting bacterial protein synthesis. Common adverse effects include nausea, diarrhea and abdominal pain. It should not be used in those with hypersensitivity to macrolides or a history of QT prolongation. Nurses monitor for therapeutic effects and superinfections, and ensure proper administration.
Clarithromycin is an antibiotic of the macrolide class used to treat infections caused by various bacteria including Streptococcus pneumoniae, Haemophilus influenzae, Mycobacterium avium, and Helicobacter pylori. It works by inhibiting bacterial protein synthesis. Common adverse effects include nausea, diarrhea and abdominal pain. It should not be used in those with hypersensitivity to macrolides or a history of QT prolongation. Nurses monitor for therapeutic effects and superinfections, and ensure proper administration.
Clarithromycin is an antibiotic of the macrolide class used to treat infections caused by various bacteria including Streptococcus pneumoniae, Haemophilus influenzae, Mycobacterium avium, and Helicobacter pylori. It works by inhibiting bacterial protein synthesis. Common adverse effects include nausea, diarrhea and abdominal pain. It should not be used in those with hypersensitivity to macrolides or a history of QT prolongation. Nurses monitor for therapeutic effects and superinfections, and ensure proper administration.
Download as DOCX, PDF, TXT or read online from Scribd
Download as docx, pdf, or txt
You are on page 1of 1
NAME OF ACTION MECHANISM INDICATION ADVERSE EFFECT CONTRAINDICATION NURSING
DRUG OF ACTION RESPONSIBILITIES
Generic Name: Antibiotic; Binds to Treatment of Antibiotic- Hypersensitivity to Observe the 12 Clarithromycin Macrolide ribosomal susceptible associated colitis, clarithromycin, other rights of nursing receptor sites infections due to other macrolide antibiotics. administration. Brand Name: of susceptible C. pneumoniae, superinfections History of QT Assess the Biaxin organisms, H. influenzae, H. (abdominal prolongation or patient before inhibiting parainfluenzae, H. cramps, severe ventricular administering Dosage: 500 protein pylori, M. watery diarrhea, arrhythmias, including the drug. mg -1 tab synthesis of catarrhalis, M. fever) may result torsades de pointes. Evaluate for bacterial cell avium, M. from altered History of cholestatic therapeutic Route: PO wall. pneumoniae, S. bacterial balance jaundice or hepatic response (relief aureus, S. in GI tract. Rarely, impairment with prior of GI symptoms). Frequency: BID pneumoniae, S. hepatotoxicity, use of clarithromycin. (8 AM, 6 PM) pyogenes, and Concomitant use with including bacterial thrombocytopenia. colchicine (in patients exacerbation of with renal/hepatic bronchitis, otitis impairment), statins, media, acute pimozide, ergotamine, maxillary sinusitis, dihydroergotamine. Mycobacterium Hepatic/ renal avium complex impairment, elderly (MAC), with severe renal pharyngitis, impairment, tonsillitis, H. myasthenia gravis, pylori duodenal coronary artery ulcer, community- disease. Patients at acquired risk of prolonged pneumonia, skin cardiac repolarization. and soft tissue Avoid use with infections. uncorrected Prevention of electrolytes (e.g., MAC disease. hypokalemia, hypomagnesemia), clinically significant bradycardia, class IA or III antiarrhythmics